Planning For Success: Development Of Diagnostic Assays For Gene Therapies
Source: Precision ADVANCE
In this video, Deb Phippard, Global Head, Research discusses -
- Gene therapy assays
- When does an assay become a diagnostic?
- Navigating the regulatory jargon: LDT, IVD, IDE, PMA, and more
- Diagnostic assay implementation
- Commercialization considerations for rare disease assays
VIEW THE VIDEO!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Precision ADVANCE
This website uses cookies to ensure you get the best experience on our website. Learn more